Apollo Hospitals Enterprise Q3 FY26 earnings call: Revenue & Margins
Q3 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹6,477Cr
- +17.2% YoY
- +4.7% QoQ
- Net profit
- ₹516Cr
- +36.1% YoY
- +4.5% QoQ
- Margin
- 15%
- +1 pp YoY
- 0 pp QoQ
Guidance rank: #6 of 34 in Healthcare Services
See the sector's top 10 — free with your mobile number.
The short version
Platform GMV growth guidance: Around 30-35% year-on-year for the full year FY '26, excluding IP/OP GMV. Platform GMV is expected to grow around 30% this financial year and about 30% next year excluding IP/OP contributions.
From Apollo Hospitals Enterprise Ltd's Q3 FY26 earnings-call transcript · updated 23 Aug 2026.
Revenue & Sales Performance
- Platform GMV growth guidance: Around 30-35% year-on-year for the full year FY '26, excluding IP/OP GMV.
- Hospital business revenue growth: Existing hospitals expected to grow at 12-14%, with additional beds adding another 3-4%.
- Pharmacy physical stores: Targeting ~600 new store additions per year, with same-store growth at about 16-18%, driven by private label and store refresh initiatives.
- Digital business (online pharmacy): GMV growing at about 30%, with an expected trajectory of 20-22% annual growth to reach INR62 billion by Q4 FY '27.
2 more points from Apollo Hospitals Enterprise Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Apollo Hospitals Enterprise Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- 1,500 new hospital beds to be added over the next year, with 50% (750 beds) operationalized in the coming year and the remaining 750 beds thereafter.
- Breakeven expected on 1,300 new beds within 2 years.
- Operationalization phased: 40-50% of beds expected to be operationalized by Q1, including facilities in Calcutta, Hyderabad, Pune, Sarjapur; Gurugram beds expected by Q2 due to delays.
2 more points from Apollo Hospitals Enterprise Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Healthcare Services
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Apollo Hospitals Enterprise Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
See what Apollo Hospitals Enterprise Ltd said on order book & pipeline — free account, 30 seconds.
Apollo Hospitals Enterprise Ltd — Quarterly revenue & net profit
Apollo Hospitals Enterprise Ltd Q3 FY26 results — key figures
| ₹ Cr | Q3 FY26 | Q3 FY25 | YoY | Q2 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 6,477 | 5,527 | +17.2% | 6,189 | +4.7% |
| Operating profit (EBITDA) | 965 | 762 | +26.6% | 924 | +4.4% |
| Operating margin | 15% | 14% | +1 pp | 15% | 0 pp |
| Profit before tax | 682 | 536 | +27.2% | 675 | +1% |
| Net profit (PAT) | 516 | 379 | +36.1% | 494 | +4.5% |
| EPS (₹) | 34.93 | 25.89 | +34.9% | 33.19 | +5.2% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q2 FY27): revenue ₹7.6K Cr, net profit ₹660 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Apollo Hospitals's management said in earlier quarters
Others in Healthcare Services this season
- Vijaya Diagnostic Centre (Q3 FY26)
FY '27 capex of INR 100-120 crores planned, supporting network expansion (Page 5). Key concall takeaways from Vijaya Diagnostic Centre's Q3 FY26 earnings call —
- Aster DM Quality (Q3 FY26)
Mature hospitals show steady revenue growth of 14%, hospitals 3-7 years old growing at 10%, and new assets under 3 years growing at 19%. Key concall takeaways…
- Chandan Healthca (Q3 FY26)
The company plans to open 100 new labs within three years, with an overall capex of INR100 crores for this expansion. Key concall takeaways from Chandan…
- Rainbow Childrens Medicare (Q3 FY26)
Revenue growth for the quarter was 12% YoY; 9% for the first 9 months of the financial year. Key concall takeaways from Rainbow Childrens Medicare Ltd's Q3…
Potential multibaggers · Q2 FY27
Potential multibaggers in Healthcare Services
on management's own guidance
- Strong growth2
- Strong growth1
- IndegeneGood growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Apollo Hospitals Enterprise Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Apollo Hospitals Enterprise Ltd Q3 FY26 results?
Platform GMV growth guidance: Around 30-35% year-on-year for the full year FY '26, excluding IP/OP GMV. Platform GMV is expected to grow around 30% this financial year and about 30% next year excluding IP/OP contributions.
What is Apollo Hospitals Enterprise Ltd share price analysis?
Apollo Hospitals Enterprise Ltd currently shows a neutral. The stock trades at a P/E of 61.0 with a market cap of ₹128,263 Cr. Investors should review the full earnings analysis for detailed insights.
Is Apollo Hospitals Enterprise Ltd planning capital expenditure?
1,500 new hospital beds to be added over the next year, with 50% (750 beds) operationalized in the coming year and the remaining 750 beds thereafter.
Keep Apollo Hospitals Enterprise Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
